<p>Trimtech and Biogen have entered into a strategic research, option and license agreement to discover and develop small-molecule protein degraders for neurodegenerative diseases from Cambridge, England. The post Trimtech, Biogen collaborate on small-molecule degraders appeared first on Longevity.Tech</p>